Guangzhou Baiyunshan Pharmaceutical (SHA:600332) 90.92%-owned subsidiary Guangzhou Pharmaceutical plans to raise between 1 billion yuan and 3 billion yuan via the issue of up to 920 million shares.
National Equities Exchange and Quotations-listed Guangzhou Pharmaceutical is pre-listing at the Guangzhou Property Rights Exchange to solicit interest, according to a weekend filing with the Shanghai bourse.
Proceeds will be used to ease liquidity pressure and boost competitiveness.